AlphaYouBBOT: Beltran Pedro discloses securities transactions
By AlphaYouPublished Form 4
Beltran Pedro
Reporting filer
Beltran Pedro reported Tax/exercise withholding in BridgeBio Oncology Therapeutics, Inc.: 1047 units of Common Stock, dated 2026-10-01. The full Form 4 contains 1 transaction entry.
- Disclosed
- Oct 5, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Beltran Pedro | 2026-10-01 | F | Tax/exercise withholding | 1047 | 3.94 | 43,529 | 4 days | Filed terms
|
Common Stock
- Owner
- Beltran Pedro
- Date
- 2026-10-01
- Code
- F
- Action
- Tax/exercise withholding
- Quantity
- 1047
- Price
- 3.94
- Following holdings
- 43,529
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-01
- transaction Form Type: 4
- transaction Code: F
- equity Swap Involved: false
- transaction Shares: 1047
- id: F1
- transaction Price Per Share: 3.94
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 43529
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Beltran Pedro: President and CEO, Director.
- F1: Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
Original sources
Prepared automatically from public filing data. Report a correction.